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Pre menstrual syndrome (PMS) is distressing psychological, physical and/ 
or behavioural symptoms. It occurs during the luteal phase of menstrual 
cycle. The significant regression of symptoms comes with onset of or 
during the period. PMS can also be defined as a combination of emotional, 
physical and psychological disturbances. It occurs after a woman’s 
ovulation, which gets end with onset of her menstrual flow. Here, in this 
review a detailed explanation about its etiology, symptoms, signs, 
diagnosis, differential diagnosis and its treatment are being described. 
Ayurveda points of view regarding PMS are also being described. 
Premenstrual syndrome can be probably correlated with Rituvyatita 
Kalaja Pitta Vata Vriddhi. As Vata dosha plays important role in 
aggravating the other Doshas as well. Vata Dosha imbalance causes the 
imbalance state of other Doshas causing premenstrual syndrome. Vata in 
association with Pitta and Kapha simultaneously vitiates Manodosha and 
Rasadhatu. Mithyahar vihar is the Samanya nidana for this syndrome.  
 
INTRODUCTION
The word pre-menstrual syndrome is 
composed of Pre means prior to; Menstrual means 
menses; syndrome means group of symptoms. It 
seems it is a collection of a group of symptoms prior 
to the menses. There is no universally agreed single 
definition for PMS. The WHO international 
classification of diseases (ICD) includes 
premenstrual tension syndrome under the heading 
“diseases of the genitourinary tract”. It is also 
known as Premenstrual Tension (PMT) and 
Premenstrual Stress. Premenstrual syndrome is a 
psychoneuroendocrine disorder of unknown 
aetiology, often noticed just prior to menstruation. 
There is cyclic appearance of a large no of physical, 
psychological and behavioural symptoms during 
the last 7- 10 days of the menstrual cycle. 
It should fulfil the following criteria (ACOG) 
 Not related to any organic lesion (without any 
physically detectable cause)  
 Regularly occurs during the luteal phase of each 
ovulatory menstrual cycle.  
 Symptoms must be severe enough to disturb the 
life style of the woman or she required medical 
help.  
 Symptom free period during rest of the cycle.  
When these symptoms disrupt daily 
functioning, these are grouped under the name Pre 
Menstrual Dysphoric Disorder (PMDD). It is the 
severe form of PMS which should recurs for at least 
two menstrual cycles for making its diagnosis. In 
the mid 1980s, a multidisciplinary US national 
Institutes of Health consensus conference on PMS 
proper criteria that were adopted by the diagnostic 
and statistic Manual III (DSM III) to define the 
severe form of this condition: originally entitled 
“late luteal phase dysphoric disorder”, it was later 
renamed “PMDD”. It is included as a psychiatric 
disorder in the 5th edition of the Diagnostic & 
Statistical Manual for mental disorders (DSM-5). 
This is extremely common in all age groups but 
especially found in child bearing age group after the 
age of 30 yrs upto 45 yrs. The age incidence of PMS 
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is said to be due to the fact that stresses are most 
severe in the third and fourth decades. It has no 
relationship with parity, but symptoms disappear 
during pregnancy and after menopause. Educated, 
professional, highly strong patients are more likely 
to complain of PMS. The exact causes are unknown, 
although several different biologic factors have 
been suggested. Of these, estrogen and 
progesterone level variation (less common in 
women with surgical oophorectomy, drug induced 
ovarian hypofunction such as with GnRH agonists 
or rare in women with anovulatory cycles), as well 
as these sex steroids influence the CNS 
neurotransmitters, noradrenaline, gamma amino 
butyric acid (GABA) and serotonin, are frequently 
studied. Sex steroids also interact with the rennin-
angiotensin-aldosterone system (RAAS) to alter 
electrolyte and fluid balance. The antimineral 
ocorticoid properties of progesterone and possible 
estrogen activation of the RAAS system may explain 
PMS symptoms of bloating and weight gain.  
Most women of reproductive age have some 
physical discomfort or dysphoria in the weeks 
before menstruation. Symptoms are often mild, but 
can be severe enough to substantially affect daily 
activities. About 5–8% of women thus suffer from 
severe premenstrual syndrome (PMS); most of 
these women also meet criteria for premenstrual 
dysphoric disorder (PMDD). Mood and behavioural 
symptoms, including irritability, tension, depressed 
mood, tearfulness, and mood swings, are the most 
distressing, but somatic complaints, such as breast 
tenderness and bloating, can also be problematic. 
We outline theories for the underlying causes of 
severe PMS, and describe two main methods of 
treating it: one targeting the hypothalamus-
pituitary-ovary axis, and the other targeting brain 
serotonergic synapses. Fluctuations in gonadal 
hormone levels trigger the symptoms, and thus 
interventions that abolish ovarian cyclicity, 
including long-acting analogues of gonadotropin-
releasing hormone (GnRH) or oestradiol 
(administered as patches or implants), effectively 
reduce the symptoms, as can some oral 
contraceptives. The effectiveness of serotonin 
reuptake inhibitors, taken throughout the cycle or 
during luteal phases only, is also well established.[1] 
AIM 
Aim of this review is to evaluate and discuss about 
Pre menstrual syndrome, its prevalence, etiology, 
sign and symptoms and its management in both 
perspective Modern as well as Ayurveda.  
OBJECTIVE 
Is to elaborate the concept regarding pre menstrual 
syndrome in both perspective Ayurveda as well as 
Modern. 
MATERIALS AND METHODS 
From Brihatrayee and other Ayurveda literatures, 
articles related to pre menstrual syndrome are 
compiled. From Modern books and research papers 
and e-sources compilation is done.  
Prevalence 
It is estimated that as many as 3 of every 4 
menstruating woman have experienced some form 
of PMS. The symptoms are mild, but 5-8% have 
moderate to severe symptoms that are associated 
with substantial distress or functional impairment. 
However, some studies suggest that upto 20% of all 
women of fertile age have premenstrual 
complaints.[2] 
Previous Indian studies have found a 20% 
prevalence of PMS in the general population & 
among there with PMS 8% had severe symptoms[3]. 
Raval et al. did a study in Gujarat among 489 college 
students and found the prevalence of PMS was 
18.4% and of PMDD was 3.7%.[4] 
Etiology  
The etiology of PMS remains unknown and 
may be complex and multifactorial. The role of 
ovarian hormones is unclear, but symptoms often 
improve when ovulation is suppressed. Changes in 
hormone levels may influence centrally acting 
neurotransmitters such as serotonin, 1 but 
circulating sex hormone levels are typically normal 
in women with PMS. Some evidence suggests that 
the disorder is related to enhanced sensitivity to 
progesterone in women with underlying serotonin 
deficiency. This mechanism may not explain all 
cases, because some patients do not respond to 
treatment with selective serotonin reuptake 
inhibitors (SSRIs). Deficiencies in prostaglandins, 
related to an inability to convert linoleic acid to 
prostaglandin precursors, may be involved in PMS. 
Genetic factors also seem to play a role, as the 
concordance rate is two times higher in 
monozygotic twins than in dizygotic twins. 
Symptoms 
A patient may complain of only one 
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Table 1: Premenstrual Syndrome symptoms 
S.No. Related to Symptoms 
1. Fluid retention  Bloating, Weight gain, Oedema, Reduced urination  
2. Pain Pelvic pain, Mastalgia (breast tenderness), Headache, Joint & muscular pain, 
Backache.  
3. Psychological  Irritability, anger, depressed mood, crying and tearfulness, anxiety, tension, 
mood swings, lack of concentration, confusion, forgetfulness, restlessness, 
loneliness, decreased self-esteem, tension. 
4. Behavioural  Lack of consciousness 
Absenteeism  
Suicidal tendency & criminal acts  
Aggression  
Indecision 
5. Nervous system  Insomnia  
Hypersomnia  
Anaemia  
Food cravings  
Fatigue 
Pricking/tingling sensation  
Lethargy 
Agitation  
Change in sex drive  
Clumsiness 
Dizziness or vertigo  




7. Skin  Acne, Oily skin, Greasy or dry hair 
Signs 
On physical examination– no abnormality is detected. The pelvic organs feel normal.  
Table 2: Research Criteria for Premenstrual Dysphoric Disorder[5] 
A. In most menstrual cycles during the past year, five (or more) of the following symptoms were present 
for most of the time during the last week of the luteal phase, began to remit within a few days after the 
onset of the follicular phase, and were absent in the week after menses, with at least one of the 
symptoms being 1, 2, 3, or 4: 
1. Markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts 2. Marked anxiety, 
tension, or feelings of being “keyed up” or “on edge” 3. Marked affective lability (e.g., feeling suddenly 
sad or tearful or increased sensitivity to rejection) 4. Persistent and marked anger or irritability, or 
increased interpersonal conflicts 5. Decreased interest in usual activities (e.g., work, school, friends, 
hobbies) 6. Subjective sense of difficulty in concentrating 7. Lethargy, easy fatigability, or marked lack 
of energy 8. Marked change in appetite, overeating, or specific food cravings 9. Hypersomnia or 
insomnia 10. A subjective sense of being overwhelmed or out of control 11. Other physical symptoms, 
such as breast tenderness or swelling, headaches, joint or muscle pain, a sensation of “bloating,” or 
weight gain  
(NOTE: In menstruating females, the luteal phase corresponds with the period between ovulation and 
the onset of menses, and the follicular phase begins with menses. In non menstruating females (e.g., 
those who have had a hysterectomy), determining the timing of the luteal and follicular phases may 
require measurement of circulating reproductive hormones.) 
B. The disturbance markedly interferes with work or school, or with usual social activities and 
relationships with others (e.g., avoidance of social activities, decreased productivity and efficiency at 
work or school). 
C. The disturbance is not merely an exacerbation of the symptoms of another disorder, such as major 
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depressive disorder, panic disorder, dysthymic disorder, or a personality disorder (although it may be 
superimposed on any of these disorders). 
D. Criteria A, B, and C must be confirmed by prospective daily ratings during at least two consecutive 
symptomatic cycles. (The diagnosis may be made provisionally before this confirmation.) 
Diagnosis
PMS must be distinguished from simple 
premenstrual symptoms (e.g., bloating, breast 
tenderness) that do not interfere with daily 
functioning and are characteristic of normal 
ovulatory cycles.[6] The three key elements of the 
diagnosis are symptoms consistent with PMS, 
consistent occurrence of symptoms only during the 
luteal phase of the menstrual cycle, and negative 
impact of symptoms on function and lifestyle.[7] 
When PMS or PMDD is suspected, patients should 
be instructed to keep a premenstrual daily 
symptom diary for several consecutive months so 
that cycle-to-cycle variability can be examined. 
Based on this diary, many women may be found to 
have non luteal symptom patterns. Standardized 
daily symptom calendars, such as the Calendar of 
Premenstrual Experiences and the Prospective 
Record of the Impact and Severity of Menstruation, 
provide reliable and convenient record. 
 Difficult to diagnose  
 No clear cause  
 Symptoms complex and vary  
 Cyclic pattern – crucial for diagnosis 
 Menstrual diary keeping – changes (physical, 
psychological) 
 Symptoms appear prior to menses & disappear 
when bleeding starts.  
 TFT (thyroid function test) – R/O other medical 
disorders  
 USG to rule out organic cause- endometriosis etc. 
Differential Diagnosis of Premenstrual 
Syndrome[8] 
Affective disorder (e.g., depression, anxiety, 
dysthymia, panic) 
Anemia 
Anorexia or bulimia  





Oral contraceptive pill use 
Personality disorder 





As the aetilogy of PMS is unknown so it is 
treated mostly empirically and symptomatically. 
Most commonly prescribed treatment is NSAIDS, 
pyridoxine, evening primerose oil, diuretics, OCP, 
Progestogens, GnRH analogues, psychotherapy, 
lastly surgery.  
Management Treatment goals for PMS are 
to ameliorate or eliminate symptoms, reduce their 
impact on activities and interpersonal relationships, 
and minimize adverse effects of treatment. 
Although numerous treatment strategies are 
available, few have been adequately evaluated in 
randomized, controlled trials. Furthermore, 
research findings can be difficult to apply because 
of the variability of inclusion criteria and outcome 
measures in clinical trials, the lack of studies 
directly comparing treatment modalities, and the 
high response rate to placebo (25 to 50 percent). 
Initially, all patients with PMS should be offered 
non pharmacologic therapy. Medication should be 
offered to patients with persistent symptoms of 
PMS and those who meet criteria for PMDD. 
Surgical treatment, principally hysterectomy plus 
bilateral oophorectomy, is controversial because it 
is irreversible and associated with significant risks. 
Surgery may be considered in severely affected 
patients who fail to respond to other therapies and 
also have significant gynecologic problems for 
which surgery would be appropriate. 
Nonpharmacologic Therapy: Non pharmacologic 
interventions for PMS include patient education, 
supportive therapy, and behavioral changes. 
Women who have been educated about the biologic 
basis and prevalence of PMS report an increased 
sense of control and relief of symptoms. Although 
not rigorously evaluated, supportive therapy may 
be responsible for the high placebo-response rates 
in clinical trials. Small comparative trials show 
some benefit for formal psychologic interventions 
such as relaxation therapy and cognitive behavioral 
therapy. Behavioral measures include keeping a 
symptom diary, getting adequate rest and exercise, 
and making dietary changes. The daily symptom 
diary may help patients identify optimal times for 
implementing behavioral and other changes to 
manage symptom exacerbations. Women report 
that maintaining a symptom diary helps them 
manage PMS or PMDD. Sleep disturbances, ranging 
AYUSHDHARA, 2020;7(6):2976-2983 
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from insomnia to excessive sleep, are common in 
women with PMS. A structured sleep schedule with 
consistent sleep and wake times is recommended, 
especially during the luteal phase. Dietary 
restrictions and exercise may also be useful in 
patients with PMS. Sodium restriction has been 
proposed to minimize bloating, fluid retention, and 
breast swelling and tenderness. Caffeine restriction 
is recommended because of the association 
between caffeine and premenstrual irritability and 
insomnia. In epidemiologic and short-term 
prospective studies, women with PMS who 
practiced aerobic exercise reported fewer 
symptoms than control subjects. 
In one randomized, placebo-controlled 
crossover trial[9] chiropractic therapy was 
associated with a decrease in PMS symptoms. 
However, this effect was only noted in patients 
randomized to initially receive chiropractic 
treatment. 
Dietary Supplementation: Dietary supplements 
that have been evaluated in women with PMS 
include vitamins (A, E, and B6), calcium, 
magnesium, multivitamin/mineral supplements, 
and evening primrose oil. Because most studies 
have been small or poorly designed, efficacy needs 
to be confirmed in large, well-designed clinical 
trials before evidence-based recommendations can 
be made. In nine randomized, controlled clinical 
trials of vitamin B6 as a single supplement or in a 
multivitamin, improvement of symptoms was 
reported, but the poor quality of the trials limits 
their usefulness.[10] Vitamin B6 should not be 
routinely recommended for women with PMS.[11] 
Studies of vitamin A do not support its use, but 
vitamin E supplementation is a recognized 
treatment for mastalgia[12]. In one randomized, 
controlled trial, the administration of 400 IU per 
day of vitamin E during the luteal phase was found 
to improve affective and somatic symptoms in 
women with PMS. [13] The ACOG recognizes vitamin 
E as a potential treatment for PMS, because of 
minimal harm and its potentially beneficial 
antioxidant effect. Supplements of calcium 
carbonate in a dosage of 1,200 mg per day for three 
menstrual cycles resulted in symptom 
improvement in 48 percent of women with PMS, 
compared with 30 percent of placebo-treated 
women. [14] Magnesium in a dosage of 200 to 400 
mg per day has shown minimal benefit in alleviating 
bloating.[15] The ACOG recommends calcium 
supplementation but not magnesium 
supplementation. Evening primrose oil, a 
prostaglandin precursor, has been studied in 
women with PMS, based on the theory of 
inadequate levels of prostaglandin E1. A systematic 
review of placebo-controlled trials of evening 
primrose oil suggested lack of benefit in PMS, 
although mild relief was demonstrated in women 
with breast tenderness. [16]  
Hormones[17] 
Hormone therapy should only be prescribed 
when other measures fail. Oestrogen, progestogen 
and androgen have all been advised and used, the 
rationale depending on different theories of the 
causation of symptoms. However, it is probably 
more effective to eliminate endogeneous hormone 
variations by the administration of daily oral 
contraceptive pills, or progestogens, e.g. deyhydro-
gesterone 20mg daily, oral medroxyprogesterone 
acetate 10-30mg daily, oral medroxyprogesterone 
acetate 10-3mg daily or depot medroxy-
progesterone acetate 150mg i.m. every 3 months.  
GnRH agonists have had success in 60-70 
percent of patients with PMS. This medical 
oophorectomy has significant side effects. 
Combining it with oestrogen– progestogen add-
back decreases the side effects but also the efficacy 
of treatment of PMS.  
Other Drugs 
Bromocriptine has been tried but it best 
relieves cyclical breast symptoms. While some of 
other symptoms are made relieved or made 
tolerable, the overall benefit is not significantly 
greater than the obtained by the combination of 
placebo therapy and a caring physician.  
When there is emotional instability and 
anxiety, mild tranquilizers are beneficial. Most 
proprietary remedies contain mixtures of vitamins 
and micronutrients while others contain 
tranquilizers, anti- histamine stimulants, and 
progestogens as well.  
Surgery 
In some extreme cases, relief may not be 
obtained with any medications. Total abdominal 
hysterectomy with bilateral salpingo-oophorectomy 
has been recommended for these women, followed 
by HRT with unopposed oestrogen. However, since 
this is an extreme step, a test with a GnRH analogue 
should be done to confirm that the procedure will 





Khushboo Jha, K. Bharathi, Kajal Jha, Sonu. Conceptual Study of Premenstrual Syndrome with Modern and Ayurveda Point of View 
AYUSHDHARA | November - December 2020 | Vol 7 | Issue 6  2981 
Prescription Medications Commonly Used in the Treatment of Premenstrual Syndrome (PMS) [18] 
Drug class and 
representative agents  
Dosage Recommendations for use Side effects 
SSRIs 10 to 
 20mg 
First-choice agents for treatment 
of PMDD, at present, only 





mild tremor, sexual 
dysfunction. 
Fluxetine (sarafem) 
Sertraline (Zoloft) 50 to 150mg  Clearly effective in alleviating 
behavioural and physical 
symptoms of PMS and PMDD.  
 
Fluvoxamine (luvox) 25 to 50mg/day  For intermittent therapy, 
administer during luteal phase 







Clearly, effective in alleviating 






275 to 550mg 
twice daily  
Effective in alleviating various 
physical symptoms of PMS but 
not breast tenderness.  
Nausea, gastric 
ulceration, renal 
dysfunction, use with 
caution in women with 
pre- existing gastro 
intestinal or renal 
disease.  
Androgens  
Danazol (Danocrine)  
100 to 400mg 
twice daily  
Somewhat effective in alleviating 
mastalgia when taken during 
luteal phase continuous therapy 
is not recommended because of 
side effects profile and cost.  
Weight gain, decrease 
breast size, deepening 
of voice, monitor lipid 
profile and liver 
function.  
GnRH agonists  
Leuprolide (lupron) 





Somewhat effective in alleviating 
physical and behavioral 
symptoms of PMS. 
Hypoestrogenic side 
effect including atrophic 
vaginitis, hot flushes, 
cardio- vascular and 
osteoporosis.  
Goserelin (zoladex) 3.6mg SC every 
month or 
10.8mg SC every 
three months.  
  
Nafarelin (synarel)  200 to 400mg 
intra- nasally 
twice daily.  
  
Histrelin (supprelin) 10mg per kg per 
day SC  
  
According to Ayurveda Point of View 
In the Ritu chakra (menstrual cycle), three phases are described in the classic texts of Ayurveda as 
well as in modern books. The phases are Rajah Kala (Menstrual phase), Ritu Kala (Proliferative phase with 










Ritu Kala (Proliferative 
phase with ovulation) 
Rituvyatita Kala (Luteal 
or secretary phase) 
Dosha Pradhanta 
(predominance) 
Vata Kapha Pitta 
Dosha Chaya  Kapha Pitta Vata 
Dosha Prakopa Vata Kapha Pitta 
Dosha Shamana Pitta Vata Kapha 
Rituvyatita Kala (phase) is governed by 
Pitta basically. Pitta is a kind of transformation 
energy. So the basal body temperature is raised by 
0.50F to 10F as said in the modern books. This is due 
to Pitta Dosha predominance by Ayurvedic 
principals and due to thermogenic effect of 
norepinephrine and progesterone by modern 
science. Pitta is formed of Agni Mahabhuta mainly. 
So the Agni of whole body rises along with the 
Updhatvagni of endometrium layer of uterus 
specifically.  
Premenstrual syndrome can be probably 
correlated with Rituvyatita Kalaja Pitta Vata 
Vriddhi. As stated in Sharangdhara Samhita,[20] Pitta 
and Kapha Doshas are Pangu and the movement of 
these Doshas is done by Vata Dosha only. So Vata 
Dosha imbalance causes the imbalance state of 
other Doshas causing premenstrual syndrome. Vata 
in association with Pitta and Kapha simultaneously 
vitiates Manodosha and Rasadhatu. Mithyahar vihar 
is the Samanya nidana for this syndrome. Mithya-
ahara, not following codes and conduct of food, 
Mithya-vihara like Ati-chintana, Shoka, Bhaya 
leads to Vata prakopa. Further exposure to Nidana 
makes Vata move in Viloma gati presented as 
Anavasthita chitta, Udvega, Glani, Rodana, Pralapa, 
Daha, Shotha, Sarvanga vedana etc. 
It is useful to eat Yava during menstruation. 
Similarly, Milk is sweet, unctuous, refreshing, body-
promoting, intellect- promoting, strength-
promoting, mind- promoting, vitalizes, fatigue-
alleviating, destroyer of internal haemorrhage, 
union-promoting in injuries, whole-some for all 
living beings. Hence, it is always better to avoid the 
factors which trigger the complications during the 
menstruation. But, now-a-days, at the era of 
globalization it is quit impossible to follow the 
Rajaswala Paricharya[21] as it is mentioned in the 
Classics. But, it can be followed at some extent such 
as these modifications in the Rajaswala Paricharya 
will help to maintain her equilibrium of health 
during the most sensitive period of menstruation. 
Some Drugs that can be used in Ayurveda 
are Yastimadhu churna, Gokshura churna, 
Dadimastaka churna, Brahmi, Ashwagandha, 
Jatamamsi and Guduchi to cope with emotional 
symptoms, Shatavari and Kumari are the best to 
deal with a Pitta imbalance. 
Some Yoga can also be prescribed along 
with medicines like Ushtrasana, Gomukhasana, 
Bhujangasana and Pavanamuktasana. Pranayamas 
like Nadi Shodhana and Anulomaviloma are also 
helpful in Vata imbalance, Naukasana and 
Dhanurasana yoga postures and Sheetali 
pranayama can be use in Pitta imbalance. 
Suryanamaskaras and spinal twists Bastrika and 
Kapalbhati in Kapha imbalance. 
CONCLUSION  
Hence, severe PMS is consistently reported 
by about 5% of all women of fertile age. The 
management of PMS is complex. At the outset it is 
important to establish a precise diagnosis and not 
rely on the patient’s own diagnosis. It is mandatory 
to separate PMS/PMDD from other diagnoses, 
particularly depression and anxiety disorders, 
premenstrual exacerbation of another disorder, or 
mild physiological symptoms requiring no more 
than reassurance; preferably this assessment 
should be done by the general practitioner before 
referral to a gynaecologist or a psychiatrist. 
Diagnosis is best achieved through daily rating 
symptoms over at least one menstrual cycle; 
clinicians can ask patients to choose their worst 
symptoms and chart the severity daily, or can select 
a validated scale such as the Daily Record of 
Severity of Problems.  
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